Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Zimmerman (1951)
Use of methylphenyl-succinimide in treatment of petit mal epilepsy.A.M.A. archives of neurology and psychiatry, 66 2
W. Lennox (1947)
Tridione in the treatment of epilepsy.Journal of the American Medical Association, 134 2
F. Zimmerman (1953)
New drugs in the treatment of petit mal epilepsy.The American journal of psychiatry, 109 10
In a search for new drugs for patients with petit mal during the past several years, it became apparent to us that contradictory reports by various investigators were largely the result of lack of uniformity in presenting data and of differences in the nature of the case load itself. We felt that since the first aspect of the problem was largely statistical, this could greatly be improved by reporting results systematically and in some detail. The second difficulty—until there is more unanimity of opinion on diagnostic category—can, we believe, be minimized by the use of identical cases for all drugs evaluated. It was also clear that the effectiveness of new compounds could not be judged by comparison with each other or with standard drugs unless a standardized method of evaluation was used for all drugs tested. Since a solution to this problem is important, both to the epileptologist and the
JAMA – American Medical Association
Published: Apr 2, 1955
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.